The @AACR report on COVID’s impact on cancer research thoroughly encapsulates the challenges faced over the last two years by PIs, clinicians, and their trainees. A cathartic read after two years of grinding out research in this field. Highly recommend. aacr.org/professionals/resea…
Interesting article on treatment of obesity in @JAMASurgery.
The oncologist in me is really happy to see the words “neoadjuvant” and “adjuvant” being used to describe the treatment of obesity. @sam_torreslandajamanetwork.com/journals/jam…
Exciting news for colorectal cancer screening and #liquidbiopsy with FDA approving ctDNA-based screening test for early stage disease. Not sensitive for adenomas, so will be interesting to see if/how it integrates into current screening guidelines. cnn.com/2024/07/29/health/fd…
At a minimum it can improve detection of early stage disease, even if unable to prevent disease by detection of pre-malignant polyps. Great potential for reducing disparities!
Day 2 of the 4th @MoffittNews Complex HPB Course started with a dicussion on contract negotiation led by Dr. Fleming. We also got to hear HPB heroine and mastersurgeon @HoggNDMD ‘s take on operative standards for pancreatic surgery.
@MHepatobiliary@DanielAnayaMD@DenboJw
Dude it’s the first week of residency.
I’ll never understand Attendings who get enjoyment out of publicly embarrassing or critiquing their trainees.
@michaelcsiah@UTSWVascular@UTSW_Surgery
BREAKING: The Biden campaign just released this devastating ad that demolishes Donald Trump for being a convicted felon. Retweet so all Americans see this.
Continuing our infrequent look at the state of AI. While LLMs are bad at generating true humor (see post from earlier this week), they are good at non-subjective tasks. We asked ChatGPT to describe laparoscopy as Shakespeare (thread 1/6):
@Laparoscopes@aminmadaniMD@rbarbosa91
The outcomes seem a little suboptimal though with a reported 50% recurrence rate at 5 years. I suspect the population being surveilled for recurrence is at MUCH higher risk than all-comers. This likely artificially raises the event rate.
Advancing care for #NETs 🦓 at #SSO2024
More data to understand the disease and direct tailored management👉🏻 single cell mass cytometry 🔬 by Eric Pletcher @DeptSurgeryCS 👇🏻